IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer

in Cancer Immunity and Immunotherapy

• Lina Somri-Gannam
• Shilhav Meisel-Sharon
• Shay Hantisteanu
• Tomer Bar-Noy
• Emiliya Sigal
• Gabriel Groisman
• Mordechai Hallak
• Haim Werner
• Ilan Bruchim

Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy

in Cancer Immunity and Immunotherapy

• Nahum Puebla-Osorio
• Natalie Wall Fowlkes
• Hampartsoum B. Barsoumian
• Kristina Xega
• Gitika Srivastava
• Claudia Kettlun-Leyton
• Sara Nizzero
• Tiffany Voss
• Thomas S. Riad
• Christina Wong

FAS gene expression, prognostic significance and molecular interactions in lung cancer

in Cancer Immunity and Immunotherapy

• Kaimin Li
• Shing Cheng Tan
• Zhihao Yang

Case report: Fatal hemoptysis after effective treatment with tislelizumab and anlotinib in pulmonary sarcomatoid carcinoma

in Cancer Immunity and Immunotherapy

• Chen-Wei Pu
• Yong-Fen Ma
• Jing-Jing Peng
• Zhen-Zhen Wang

Effects of intratumoral microbiota on tumorigenesis, anti-tumor immunity, and microbe-based cancer therapy

in Cancer Immunity and Immunotherapy

• Jingwei Zheng

Editorial: Insights and implications of mechanisms shaping glioma immune landscape, immunotherapy resistance, and relevant translational research

in Cancer Immunity and Immunotherapy

Progression of oncolytic virus in liver cancer treatment

in Cancer Immunity and Immunotherapy

• Xuesi Hua
• Siyu Xuan
• Yangyang Tang
• Shilin You
• Shang Zhao
• Ye Qiu
• Yinqing Li
• Yongqing Li

Exploring the impact of HDL and LMNA gene expression on immunotherapy outcomes in NSCLC: a comprehensive analysis using clinical & gene data

in Cancer Immunity and Immunotherapy

• Jingru Li
• Jingting Wang
• Banwei Cao

The sympathetic nervous system shapes the tumor microenvironment to impair chemotherapy response

in Cancer Immunity and Immunotherapy

• Annabel V. Manoleras
• Erica K. Sloan
• Aeson Chang

Case report: Intrapleural plus systemic Tislelizumab injection combined chemotherapy in RET gene fusion-positive lung adenocarcinoma presenting refractory malignant pleural effusion

in Cancer Immunity and Immunotherapy

• Dong Qiu
• Xiao-Hui Zhang
• Yang Wang
• Cheng Chen

Revealing the mechanisms of RAC3 in tumor aggressiveness, the immunotherapy response, and drug resistance in bladder cancer

in Cancer Immunity and Immunotherapy

• Hanyuan Gao
• Yanru Qiu
• Xueqin Zheng

Complete response to disitamab vedotin in HER2-low metastatic endometrial carcinoma: a case report and review of the literature

in Cancer Immunity and Immunotherapy

• Hu Feng
• Shasha Bi
• Shanshan Sun
• Hongbo Yang
• Haoxing Zhou
• Jingjing Mao

Sintilimab-induced myocarditis suspected in a patient with esophageal cancer and followed septic shock: case report and literature review

in Cancer Immunity and Immunotherapy

• Qihao Zhou
• Zhiquan Qin
• Guoqing Wu
• Peiyuan Yan
• Qunjiang Wang
• Jing Qu
• Jiahong Jiang

DSP-0509, a TLR7 agonist, exerted synergistic anti-tumor immunity combined with various immune therapies through modulating diverse immune cells in cancer microenvironment

in Cancer Immunity and Immunotherapy

• Yosuke Ota
• Ryosaku Inagaki
• Kentaro Sumida
• Megumi Nakamura
• Yasuhiro Nagai
• Setsuko Yamamoto

Hepatocellular carcinoma cells induce γδ T cells through metabolic reprogramming into tumor-progressive subpopulation

in Cancer Immunity and Immunotherapy

• Jinkun Xia
• Chaoyu Wang
• Biao Li